Bet­ting on cell mem­o­ry, Ab­b­Vie pays Im­munome $30M up­front to fur­ther an­ti­body re­search

Ab­b­Vie has tapped Im­munome’s dis­cov­ery plat­form in a heav­i­ly back­end­ed part­ner­ship and op­tion agree­ment in a bid to dis­cov­er 10 an­ti­body-tar­get pairs from three as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER